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Abstract 
Objectives: Neglected tropical diseases (NTD), account for a large proportion of the global disease burden, and their 
control faces several challenges including diminishing human and financial resources for those distressed from such 
diseases. Visceral leishmaniasis (VL), the second-largest parasitic killer (after malaria) and an NTD affects poor popula-
tions and causes considerable cost to the affected individuals. Mathematical models can serve as a critical and cost-
effective tool for understanding VL dynamics, however, complex array of socio-economic factors affecting its dynam-
ics need to be identified and appropriately incorporated within a dynamical modeling framework. This study reviews 
literature on vector-borne diseases and collects challenges and successes related to the modeling of transmission 
dynamics of VL. Possible ways of creating a comprehensive mathematical model is also discussed.
Methods: Published literature in three categories are reviewed: (i) identifying non-traditional but critical mechanisms 
for VL transmission in resource limited regions, (ii) mathematical models used for dynamics of Leishmaniasis and other 
related vector borne infectious diseases and (iii) examples of modeling that have the potential to capture identified 
mechanisms of VL to study its dynamics.
Results: This review suggests that VL elimination have not been achieved yet because existing transmission dynam-
ics models for VL fails to capture relevant local socio-economic risk factors. This study identifies critical risk factors of 
VL and distribute them in six categories (atmosphere, access, availability, awareness, adherence, and accedence). The 
study also suggests novel quantitative models, parts of it are borrowed from other non-neglected diseases, for incor-
porating these factors and using them to understand VL dynamics and evaluating control programs for achieving VL 
elimination in a resource-limited environment.
Conclusions: Controlling VL is expensive for local communities in endemic countries where individuals remain in the 
vicious cycle of disease and poverty. Smarter public investment in control programs would not only decrease the VL 
disease burden but will also help to alleviate poverty. However, dynamical models are necessary to evaluate interven-
tion strategies to formulate a cost-effective optimal policy for eradication of VL.
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Introduction
Visceral leishmaniasis (VL) is a vector-borne infectious 
disease that is transmitted to humans by infected sand-
flies and is the second-largest parasitic killer in the world 
after malaria [1, 2]. If left untreated, most cases result in 
death within 2–3  years of clinical manifestation [3, 4]. 
In 2015, more than 90% of new cases of VL reported to 
the World Health Organization (WHO) occurred in Bra-
zil, Ethiopia, India, Kenya, Somalia, South Sudan, and 
Sudan [2]. VL is identified as a Neglected Tropical Dis-
ease (NTD) by the WHO because it is endemic in several 
poverty stricken regions of the world [5], although pre-
ventive measures and successful treatment is common 
in most developed countries [6]. Many people living in 
these impoverished regions are daily-wage workers, for 
whom infection with a disease like VL restricts the bread-
winners’ ability to provide livelihood for their families. 
Moreover, the cost of treatment and duration of stunted 
income pushes them into a vicious cycle of further hard-
ship and irrecoverable financial deprivation. Although 
local government authorities and the WHO have devised 
several control programs (such as integrated vector man-
agement program and active surveillance) to lower the 
burden of VL in these regions [7], the VL endemicity 
always creeps back after a brief period of relief. This inef-
fectiveness has been attributed to several factors, includ-
ing severe under-reporting of cases and death due to VL, 
lack of clarity in the etiology of the disease (example, con-
tribution asymptomatic infections have on transmission 
is not known [8]), and limited estimation of reservoirs 
of the infection (example, distribution of post-kala-azar 
dermal leishmaniasis is unknown [9]). Thus, the intensity 
and extent of the control programs have been in con-
flict with the magnitude of the true VL burden. In such 
resource-limited regions mathematical models can help 
shed light on respective contribution of several of these 
challenges to the VL endemicity (including identifying 
cost-effective driving mechanisms), as it has done for 
other infectious diseases like malaria. Hence, immediate 
attention from the modeling community is in dire need.
In the past, the WHO has set several elimination tar-
get dates for VL for years 2010 and 2015, which could not 
be achieved in the Indian subcontinent [10]. The primary 
reason for this shortcoming may be the ineffective imple-
mentation of policies in the under-developed regions 
affected by VL. Mathematical modeling approaches in 
conjunction with model guided additional field research 
in India could be a turning point for achieving optimal 
program implementation and may help to (1) quantify 
the “true” burden of VL in Bihar where it has proven to 
be particularly difficult to eliminate, (2) investigate the 
potential mechanisms for the spread of the Leishmania 
parasite, and (3) suggest optimal vector control programs 
that may help in achieving the WHO goal of elimination 
of VL by the year 2017 [11]. The target of the VL elimi-
nation program is to reduce the annual incidence to less 
than 1 per 10,000 at the district or sub district level in 
South Asia by 2017 [12–14]. However, the incidence in 
some parts may be around 20 cases per 10,000 [12, 14, 
15].
Since Sir Ronald Ross’ first paper using a math-
ematical model to study the transmission dynamics of 
malaria in 1906, there have been many modeling stud-
ies focusing primarily on vector-borne disease [16]. 
Existing studies of VL and other NTDs have been 
either limited in their understanding of the transmis-
sion dynamics of the disease or fail to capture critical 
local socio-economic factors. Hence, more studies are 
needed on neglected tropical diseases such as VL, clari-
fying unknown aspects of etiology and modeling based 
long term evaluation of dynamical interventions. Our 
main objective in this study is to suggest mathematical 
modeling approaches for capturing identified regional 
issues that may be critical in better evaluating control 
programs; thereby, developing optimal cost-effective 
intervention strategy and timely achieving elimination 
goals. We discuss specific features of VL (including 
treatment availability, living conditions, effect of social 
status, and implementation cost of control programs) 
that should be incorporated into quantitative meth-
ods. We assessed the strengths and limitations of ana-
lytical models in addressing the risk factors and VBD 
transmission. Finally, we provide recommendations for 
future research on modeling VL dynamics and impact 
of risk factors on VL transmission.
Methods
Search strategy
The following protocol was established for this review. We 
searched Google Scholar, PubMed and Web of Knowl-
edge to find articles focusing on “mathematical modeling 
of vector-borne diseases” (VBD), “Visceral Leishmaniasis”, 
“Kala-azar”, “risk factors of Leishmaniasis”, and “dynam-
ics of Leishmaniasis”. The goal was to identify factors that 
have been modeled and studied for understanding VL 
dynamics and inform modeling strategies that needs to be 
undertaken in order to systematically address challenges 
for controlling (eventually eliminating) VL from resource 
limited regions. For the theoretical literature, we included 
epidemiological and public health studies that addressed 
important technicalities of modeling the dynamics of vec-
tor borne infectious diseases, including, economic mod-
els, uncertainty and sensitivity analysis, and optimization 
models. We also considered studies that evaluate impact 
of socio-economic conditions on patterns of tropical 
diseases.
Page 3 of 14DebRoy et al. Emerg Themes Epidemiol  (2017) 14:10 
Selection criteria
Our search criterion was: articles that contain visceral 
leishmaniasis (VL) AND VBD model AND risk factors 
of VL. Our eligibility criteria were articles that: (i) were 
published in peer reviewed journals and focused on 
countries affected with neglected tropical diseases; (ii) 
aimed to model risk factors for similar (to VL) vector-
borne diseases; (iii) employed mechanistic models to 
understand VL dynamics; and (iv) establish critical risk 
factors from cross-sectional and longitudinal empiri-
cal VL (in South Asia) studies. A scheme of the selection 
in outlined in a flowchart in the Additional file 1: Figure 
S4. To identify data-supported risk factors, we reviewed 
the literature based on searches using the term visceral 
leishmaniasis with the subheading risk factors, and the 
geographic terms India or Bangladesh or Nepal. Articles 
published from 1985 through September, 2016 in Eng-
lish were included. We included all studies that explic-
itly addressed factors associated with risk of VL in South 
Asia, the objectives, design, outcome measures and anal-
yses were clearly described, and judged to be adequate 
based on the methods and data presented. A formal com-
parison for studies on risk factors was impossible due to 
scarce data from different time points, and non-compara-
ble study designs and implications. We excluded studies 
that did not incorporate disease transmission dynamics 
such as studies with cost-effectiveness, and decision tree 
type models. We also excluded opinion papers, review 
articles, qualitative VL reports and modeling studies 
comparing different regions. More details on how many 
articles were retrieved by the search and how many were 
excluded on each topic were given in first paragraph of 
Results section.
Results
We collected 107 articles on topics mentioned in the 
Search Strategy section (Additional file  1: Figure S4). 
Among these 6 articles (out of 11 resulted from key-word 
search)were on general epidemiological description of 
family of leishmaniasis other than visceral leishmaniasis 
and 3 articles (out of 7) were on other vector borne dis-
eases not similar to VL. Hence, these articles were not 
incorporated in the review. A total of 65 articles were 
studied on risk factors of visceral leishmaniasis, how-
ever, 43 articles were eventually chosen for review based 
on the consistent findings of risk factors within them 
and our selection criteria. The risk factors in these 43 
articles were grouped under six categories: Atmosphere 
(20/31 articles were selected), Access (6/9), Availability 
(4/7), Awareness (4/5), Adherence (7/10) and Accedence 
(2/3). The 24 articles found in the databases are on the 
dynamics of related (to Leishmaniasis) vector borne 
diseases while 12 articles present interesting results on 
transmission dynamics of Leishmaniasis. Three addi-
tional articles on dynamics of Leishmaniasis were not 
incorporated in the review as their primary goal was 
mathematical analysis rather than implications for the 
Leishmaniasis.
Identified VL risk factors: challenges for leishmaniasis 
transmission dynamics in resource‑limited regions
The depth and complexity of the socio-economic chal-
lenges of a neglected tropical disease dynamics at the 
grassroots level may seem disparate when consider-
ing them individually. Thus, to better comprehend the 
nature of obstacles in the transmission process, we clas-
sified some of the key issues into the six categories viz., 
atmosphere, access, availability, awareness, adherence 
and accedence (6 A-s). We note that these 6 As in turn 
can be grouped into either inculcation or infrastructure 
(2 I-s) (Fig. 1). Endemicity of VL in the region is fueled 
by the deficiency in the 2 I-s, which in turn stems from 
the sheer poverty in the affected area. Ultimately, it is 
the poverty which cannot bear the cost of prevention, 
and leads to a vicious cycle of VL dynamics there. In this 
review we focus on the state of Bihar, which holds around 
80% of India’s VL cases [17], and its neighboring coun-
tries of Nepal and Bangladesh where the disease dynam-
ics are similar. We proceed to describe the relevance of 
this 6 A-s. Some key features defining the 6 A-s are repre-
sented in Fig. 1.
Atmosphere
In the state of Bihar, the worst affected areas are in 
remote agricultural villages. Studies have revealed sev-
eral living conditions positively correlated with higher 
prevalence of leishmaniasis. In two independent stud-
ies, factors like mud plastered houses, vegetation and 
bamboo near the house, and granary inside the house 
were found to significantly contribute to leishmaniasis 
[18, 19]. Other systematic studies in the subcontinent 
with similar geographical settings (Uttar Pradesh, India; 
West Bengal, India; Terai, Nepal; Mymensingh, Bangla-
desh) have found that living conditions with cracked mud 
walls, damp floors, and close proximity to a water body 
are risk factors for leishmaniasis [20]. Also, a high density 
of occupants in a household with more than three peo-
ple per room were found to increase transmission [19, 
21–28].
It is well known that sand-fly bites thrive during the 
warmer months (March–June, October in India), and 
late in the evening [29]. The role of climatic factors on 
transmission dynamics of vector-borne diseases has been 
thoroughly studied in the literature [30, 31]. The hot 
Indian summer in combination with lack of electricity 
often lead people to sleep outdoors, which increases the 
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number of sand-fly bites and hence the risk of contract-
ing leishmaniasis [23, 25]. Understandably, proper use of 
bed-nets have been found to have a protective effect on 
people across several studies, and sleeping on a cot (ver-
sus on the floor) also demonstrated a protective effect 
as well [21, 23, 24, 26–28]. Proximity to domesticated 
animals is found to play a complex role in containing, 
spreading and serving as a possible reservoir of the para-
site [32]. For example, some studies found that proximity 
to livestock provided a protective effect against leishma-
niasis as livestock get bitten more instead of humans [24, 
25], whereas in Uttar Pradesh, India, the risk of leishma-
niasis was found to increase with increased numbers of 
cattle in the vicinity of a household because of large num-
ber of sandflies were attracted to cattle sites than to other 
livestock sites [23].
Access
Currently, therapeutic interventions for Kala-azar (Indian 
VL) are significantly subsidized by the Ministry of Health 
in India (National Vector Bourne Disease Control Pro-
gram’s Kala-azar Elimination Initiative under the Govt. 
of India). In spite of the subsidize, estimates suggest that 
80% of the outpatients and 57% of the inpatients are han-
dled in the private sector (The World Bank report, 2001 
[33]). Non-Government Organizations (NGOs) in Bihar 
usually provide awareness and education programs, car-
ryout research, and provide access to regular health ser-
vices. Ninety percent of Bihar’s population lives in rural 
areas where less than 1% of health services are provided 
by not-for-profit NGOs (The World Bank, 2001 [33]). 
Patients in rural areas travel on average much further for 
treatment than patients in urban areas. Thus, access to 
healthcare can be tricky at present and efforts need to be 
made to encourage the set-up of temporary mobile clin-
ics in harder to reach areas and to encourage people to 
seek out certified treatment [3]. Bihar is the poorest state 
in India, where the “caste” (proxy for social standing) of 
a person is born into affects almost every aspect of the 
social conduct he/she receives their entire life. [34] Mar-
tinez et al. found that the people of lower caste are con-
sistently being seen by a doctor at a more advanced stage 
of VL than those of a higher caste [35]. In fact, according 
to the last article, most VL patients in the disadvantaged 
caste see a doctor more than eight weeks post symptom 
onset, which includes a larger spleen and lower hemo-
globin level than normal. Thus, efforts need to focus 
more on the people of lower caste to diminish the dispar-
ity in healthcare; only then can planned control measures 
effectively reduce the overall burden of VL.
Availability
The WHO recommends the use of a single dose of 
Amphotericin B as the first line of treatment in the Indian 
sub-continent [36]. However, daily injections of Pentava-
lent Antimonials (SSG) for 20–30 days and 15 injections 
of Amphotericin B every other day are still more widely 
used in India (NVBDCP). The availability of drugs in a 
Fig. 1 A vicious cycle of socio-economic challenges and difficulty to access disease interventions
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timely manner is dependent on several factors including 
the affordability of a drug by the government, reason-
able forecasting of the quantity of drug required (to avoid 
shortage as well as waste), proper storage and distribu-
tion of the drugs throughout the lengthy route from the 
manufacturer to the affected people, avoiding cheaper 
counterfeit drugs and also drug legislation [37].
Awareness
‘Awareness’ can be defined as knowledge regarding the 
etiology of the disease which would help local individuals 
to prevent infection and to look out for VL symptoms and 
seek medical attention sooner rather than later. Figure 2 
shows some social aspects for which awareness programs 
may be needed as a prevention for VL. Lack of awareness 
causes a disease which is curable upon treatment, to end 
up causing death. Even symptomatic VL-infected people 
mix in the population freely, thus considerably increas-
ing the chances of transmission. In a study on Nepal 
(which shares a border with Bihar) by Rijal et  al. [38] it 
was found that affected people from the poorest strata of 
the community preferred to visit a private doctor or local 
faith healer over public health clinics, leading to lower 
short term cost but higher long term costs for these indi-
viduals because of inconsistent diagnosis and under par 
treatment. Moreover, debts acquired during this period, 
in addition to lack of income (the earning adult being ill), 
creates a major financial abyss which is almost impossi-
ble to recover from. Thus, it is not sufficient that the gov-
ernment provides free treatment to the people, it is also 
necessary to disseminate that information in an effective 
manner to every strata of people in the affected region. 
In a study in Brazil, awareness was spread in communi-
ties through educating school children, who in turn were 
assigned to discuss interventions mentioned in student’s 
homework assignments with their family members [39]. 
This intervention improved awareness significantly.
Adherence
Non-adherence to treatment is a major factor contrib-
uting to the high development of resistance to pentava-
lent antimonials in the population exposed to VL in the 
Indian sub-continent [37]. This resulted in discontinu-
ing it as a first line of treatment for VL. There are several 
major factors which contribute to non-adherence in the 
region including being male, older than 35 years of age, 
Fig. 2 Cartoon reflecting social aspects on which awareness programs to control spread of VL can be designed to reduce disease burden
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lack of knowledge about the consequences of incomplete 
treatment leading to patients stopping treatment once 
the symptoms are relieved, and the financial loss due to 
reduced days of productivity while on therapy [40, 41]. It 
has been well documented in a 2000–2010 cohort study 
in Nepal that another disease, Post Kala-azar Dermal 
Leishmaniasis (PKDL), a sequel and reservoir for VL, was 
more common in patients who were inadequately treated 
during VL versus the ones who adhered to the full course 
of treatment. A 29.4% PKDL prevalence was observed 
in patients who were inadequately treated for VL with 
sodium stibogluconate (SSG) versus 2.0% PKDL preva-
lence in VL patients who completed the full SSG course 
[42]. As observed by Rijal et  al. [38] loss of productiv-
ity implies no income at all for the poor families. Farm-
ers are unable to attend to their fields, possibly during 
very important farming phases which results in lowered 
income for a considerable period of time. A lot of people 
in the poorest section of society in Bihar are also daily-
wage earners and each missed day of work might present 
dire consequences for the entire family. To survive this 
period, the family takes out loans from private lenders at 
high interest, ultimately leading them to further poverty.
Accedence
‘Accedence’ is defined as the acceptance to undergo test-
ing and treatment for PKDL, which can occur in patients 
who have recovered from VL post-treatment caused by 
the same pathogen. As reported by Desjeux et al. in 2013, 
patients with PKDL serve as a reservoir of VL and it is 
unlikely that VL can be eradicated without addressing 
the issue of diagnosing and treating PKDL [43]. In fact, 
aggressive measures are required to encourage people to 
consult a doctor in case of any persistent skin lesions, and 
once diagnosed these should be treated with Ampho-
tericin B, which has been found effective in the Indian 
sub-continent. As reported by Thakur et  al., attempts 
were made to fast-track diagnosis and treatment of PKDL 
in several badly affected districts of Bihar and yielded a 
very positive outcome [44]. However, these efforts need 
the support of the local governmental authorities to con-
tinue and succeed where it is most needed. It is evident 
that aggressive control measures are necessary to address 
every issue and to ultimately alleviate the burden of VL 
from Bihar. However, several of the issues arise from lim-
ited resources in the affected region and thus the control 
strategies should be carefully weighed by importance and 
cost-effectiveness [45]. Moreover, it is not only important 
to take drastic measures using the one-time funds gener-
ated for this purpose, but it is essential that powerful and 
sustainable changes in the system are established through 
easy and systematic ways of approaching the difficul-
ties, which can only be attained by identifying critical 
mechanisms of the system. Mathematical models are one 
of the best methods to cheaply and systematically iden-
tify driving factors.
Review of leishmaniasis dynamical modeling studies
Despite the incalculable harm and countless challenges 
leishmaniasis inflicts on populations around the globe, 
only a handful of publications address the problems from 
a mathematical modeling perspective. In fact, a recent 
review by Rock et  al., which tabulates all mathemati-
cal models of VL, found only twenty-four articles using 
mathematical models for VL, several of which used the 
same base model structure [46]. Of these twenty-four 
articles, only seven addressed VL in the Indian sub-
continent. Arguably, one of the greatest modeling chal-
lenges is the limited understanding of the leishmania 
pathogen, the sandfly vector, and how disease manifests 
in humans. Dye et  al. [47] spear-headed the application 
of mathematical models to leishmania dynamics. The 
authors developed a simple discrete-time model with 
Susceptible, Infected, and Resistant humans to study the 
mechanism behind inter-epidemic periods observed in 
VL cases between 1875 and 1950 in Assam, India. Coun-
ter to the existing theory of the time, the model demon-
strated that the observed inter-epidemic patterns could 
be explained by intrinsic factors in leishmania transmis-
sion. This modeling effort also stressed the significance of 
PKDL and sub-clinical infections in determining whether 
a region will have endemic or epidemic leishmaniasis. 
A few years later, Hasibeder et al. [48] published a com-
partmental delay-differential equation model for canine 
leishmaniasis. This model accounts for two types of dogs: 
those that will develop symptoms, and those that will 
remain asymptomatic, following infection by a sandfly. 
The model also explicitly describes the infection dynam-
ics of the sandfly vector and considers a fixed delay rep-
resenting the extrinsic incubation period. The authors 
take a heuristic approach to derive a formula for the basic 
reproduction number R0, the number of secondary sand-
fly infections resulting from a single infected sandfly, in 
an otherwise fully susceptible population. Although this 
model addresses two important aspects of the natural 
history of the disease that may be extended to human 
VL, namely the asymptomatic human and infected vec-
tor populations, the model does not consider the asymp-
tomatic population to be an infectious reservoir, assumes 
constant human and vector population sizes, and omits 
the effects of seasonality. The model does, however, 
introduce heterogeneous biting, determined by a dog’s 
“occupation”. The mathematics developed in [48] was 
applied to age-structured serological data for the dog 
population in Gozo, Malta in [49], and provided esti-
mates for R0. This modeling work was extended in [50] 
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to include zoonotic transmission, that is, humans, dogs, 
and sandflies, were explicitly modeled. Dye conducted a 
sensitivity analysis to determine which of three control 
measures would be most effective in decreasing disease 
prevalence. Their results suggest vector control and vac-
cination of the human or dog population would be more 
effective than treating or killing infected dogs. However, 
in their model, they assumed that any treatment of dogs 
results in full recovery and the efficacy of vaccination is 
extremely high. These assumptions may not be com-
pletely realistic.
More recently, Stauch et al. developed a more compre-
hensive model of VL for the Indian subcontinent [51], 
and later extended it to include drug-resistant and drug 
sensitive L. donovani parasites, with a focus on Bihar, 
India [52]. The model proposed by Stauch et  al. [51] 
extended the basic susceptible-infectious-recovered (SIR) 
model structure for the human population by segmenting 
the infected stage into five distinct stages according to an 
individual’s infection status determined by the results of 
three diagnostic markers. These diagnostic markers were 
(1) PCR, the earliest infection marker, (2) DAT, which 
measures antibody response, and (3) LST, which can 
detect cellular immunity. The model also includes treat-
ment of symptomatic VL cases, treatment failure, relapse 
characterized as PKDL, PKDL treatment, and HIV-
co-infection (described in their Additional file  1: Fig-
ure S4). The sandfly population is modeled using an SEI 
(Susceptible-Latent-Infectious) model. Treatment of VL 
is divided into first and second-line treatment, and treat-
ment-induced mortality caused by drug-toxicity is con-
sidered. The model was fit to data from the KalaNet trial 
using Maximum Likelihood. The authors explored sev-
eral intervention strategies, including treatment, active 
case detection, and vector control. Although the authors 
warn that their model assumes homogeneous transmis-
sion, ignoring possible clustering of cases within affected 
households, their modeling approach and parameter esti-
mation argues that the large asymptomatic reservoir pre-
cludes the ability for a treatment-only control program 
to attain the desired target of less than 1 case per 10,000 
individuals annually. Vector-based control is much more 
promising, but the authors estimate it can only reason-
ably reduce VL incidence to 18.8 cases per 10,000. Con-
sequently, the authors emphasize the need for active case 
detection, effective treatment of PKDL, and vector con-
trol to achieve VL elimination.
Based on the model in Stauch et  al.  [51], and follow-
ing up on their finding that treatment of VL does lit-
tle to reduce transmission, Stauch et al. investigated the 
uncertainty in their parameter estimates and explored 
the efficacy of different vector-based control measures 
[53]. They estimated that R0 for VL is approximately 4.71 
in India and Nepal, and that reducing the sandfly popula-
tion by 79% via reduction of breeding sites, or reducing 
the sandfly population by 67% through increasing sand-
fly mortality, are both sufficient to eliminate the L. dono-
vani parasite in the human population. The authors argue 
that recent evaluations of IRS (indoor residual spraying) 
efficacy suggest that elimination should be possible, with 
the caveat that the situation may change if insecticide 
resistance emerges. However, vector management using 
LLIN’s (long-lasting insecticide-treated nets) or EVM 
(environmental management) would not be sufficient to 
achieve elimination. The authors emphasize the need to 
study infection rates, the parasite dynamics in both the 
human and vector population, animals serving as alter-
nate hosts or potentially infectious reservoirs, and the 
contribution of the asymptomatic population. Further-
more, Stauch et  al. suggest extensions of the determin-
istic modeling framework to include heterogeneity in 
population and seasonality.
Stauch et  al. [52] extended the model from their pre-
vious study [51] to include both drug-resistant and 
drug-sensitive parasites. The authors considered five 
mechanisms by which the fitness of the resistant strain 
may differ from the sensitive strain: (1) increase probabil-
ity of symptoms, (2) increase parasite load, (3) increase 
infectivity of asymptomatic humans, (4) increase trans-
mission from symptomatic and asymptomatic host to 
vector, (5) increase transmission from vector to host. 
Simulations of this extended model indicate that a treat-
ment failure rate over 60% is required to explain observa-
tions in Bihar. Furthermore, observations in Bihar cannot 
be explained without assuming an increase in fitness in 
resistant parasites. The authors explain that it is more 
likely that the necessary additional fitness is transmis-
sion-related rather than disease-related. Unfortunately, 
their results also suggest that once a more fit resistant 
parasite has been introduced, that parasite will eventu-
ally exclude the sensitive parasite, even in the absence of 
treatment.
The work of Mubayi et al. is the first to use a rigorous, 
and dynamic model to estimate underreporting of VL 
cases at the district level in Bihar, India [3]. The authors 
designed a staged-progression model, composed of a 
system of nonlinear, coupled, ordinary differential equa-
tions. In a typical SIR type epidemic model, the inbuilt 
assumption is that an individual stay in each infection 
category for an exponentially distributed waiting time. 
The stage-progression model considers a series of same 
infection category (for examples, I1, I2, . . . , In for infec-
tious category I), each with same average waiting rate. 
It exploits the fact that the sum of n independent expo-
nential distributions with rate parameter  is a gamma 
distribution with shape parameter n and scale parameter 
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1/ (Ŵ(n, 1/)), which helps in capturing the observed 
variability in waiting time in a epidemiological category 
such as incubation period, infectious period, and treat-
ment duration. Furthermore, the authors address the dif-
ferences between public and private health care facilities 
in their treatment and reporting practices by assuming a 
fraction of infected individuals p seek treatment in pub-
lic health care facilities, and the remaining proportion 
seek treatment in private clinics. Building an empirical 
distribution for this parameter p and deriving a relation-
ship between model parameters and monthly reported 
incidence data allowed the authors to estimate the degree 
of underreporting for each district for the years 2003 and 
2005. This model analysis informed by incidence data 
revealed that districts previously designated as low-risk 
areas for VL are actually likely to be high-risk: the true 
burden masked by underreporting.
ELmojtaba et al. presented a more classical approach to 
modeling VL, with a focus on Sudan, in [54–56]. Because 
leishmaniasis in the Sudan is zoonotic, the authors 
included the dynamics of an animal (rodents and dogs) 
reservoir in [54]. This baseline model is extended in [55] 
to address parasite diversity, and in [56] to explore the 
potential impact of mass vaccination in the presence of 
immigration.
More recently, Sevá et al. [57] developed a mathemati-
cal model for human and canine zoonotic VL in Brazil. 
The focus of this study was to test the efficacy of exist-
ing canine-based VL prevention and control methods: 
insecticide-impregnated dog collars, culling, and vacci-
nation. By optimizing each of these control strategies in 
an ordinary differential equation model, while accounting 
for their respective costs, the authors were able to recom-
mend a 90% coverage of the dog population with insecti-
cide-impregnated collars as a control strategy that is easy 
to adopt and could, over time, eliminate VL in the region. 
All of these modeling efforts (summarized in Table  1) 
have either contributed to our understanding of VL or 
highlighted the need for better data to construct and vali-
date future models of VL. However, there are currently 
no models, to the best of our knowledge, that attempt to 
link socio-economic factors, like the 6 A’s discussed in 
“Identified VL risk factors: challenges for leishmaniasis 
transmission dynamics in resource-limited regions” sec-
tion, to VL disease transmission.
Models of infectious diseases incorporating 
socio‑economic risk factors
In this section, we provide some examples of pub-
lished mathematical modeling studies (summarized in 
Table  1) where researchers have attempted to incorpo-
rate some of the factors mentioned above and studied 
their role in the transmission dynamics of infectious 
and physiological diseases. Existing models of visceral 
leishmaniasis, though limited in number as compared 
to diseases like malaria and dengue, have incorporated 
some of the biological complexity, contributing to a more 
developed understanding of the disease. However, to 
formulate applicable control measure recommendations 
with cost-estimation, models which can simultaneously 
incorporate the discussed risk-factors explicitly would be 
necessary. Many of the techniques to incorporate these 
factors individually can be drawn from the literature 
regarding heavily studied diseases like HIV, malaria, and 
tuberculosis [58–60].
Modeling atmosphere
In a simplistic mathematical model we can incorporate 
several risk factors associated with ambience implicitly 
through the interpretation and calculation of the model 
parameters. For example, the transmission parameter 
can be considered as a product of the predominant type 
of housing, density of vegetation around houses, number 
of domesticated animals, and number of inhabitants in a 
house [58].
Modeling adherence
Lipsitch et  al. addressed adherence to treatment and 
its role in promoting drug resistance in a mathemati-
cal model for tuberculosis (TB) in the presence of bac-
terial heterogeneity [59]. To model non-compliance to 
drug therapy, the authors assumed that non-compliant 
patients adhere to the treatment regimen when bacterial 
loads are above a certain threshold, and will halt treat-
ment when bacterial loads fall below this threshold, that 
is,
where B(t) is the bacterial load at time t and Nmin is the 
threshold minimum bacterial load under which drug 
treatment is discontinued. The parameter K is critical 
bacterial load where adherence will become one-half 
and α is the rate at which the individual adhere to treat-
ment per unit of bacterial load. Simulation and analysis 
of their stochastic-deterministic hybrid model illustrated 
that non-compliance is one mechanism that can give 
rise to bacteria resistant to one or more drugs in a multi-
drug therapy. Furthermore, the authors noted that the 
pattern of resistance driven by non-compliance more 
closely resembled observations of patients on multi-
drug therapy, compared with the pattern of resistance 
promoted by bacterial heterogeneity. Consequently, the 
model suggests that non-compliance plays a larger role 
than heterogeneity of the bacteria population in promot-
ing resistance during multi-drug therapy. The authors 
Adherence_level(t) =
{
αB(t)
K+B(t) if B(t) ≥ Nmin
0 if B(t) < Nmin
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noted that an exception to this pattern occurred in 
HIV-positive TB patients. The modeling assumption for 
non-compliance in this TB model addresses one of the 
‘adherence’ concerns discussed in “Identified VL risk fac-
tors: challenges for leishmaniasis transmission dynamics 
in resource-limited regions” section, namely that patients 
often stop treatment once symptoms are relieved, sug-
gesting a possible framework in which to study adherence 
to treatment, treatment failure, and if tied to a popula-
tion-level model, the spread of drug resistant parasites in 
VL-endemic regions.
Adherence to treatment is also a concern in diabetes 
patients, despite the fact that non-adherence increases 
the likelihood for stroke and other potentially fatal com-
plications. Mason et al. [61] developed a Markov Decision 
process (MDP) model to study the timing of treatment 
Table 1 Modeling studies, included in the review, that considers local risk factors and the transmission dynamics of dis-
eases
 x in the Table indicate absence of the information related to column heading
Reference Study area (period) Disease Data Model type 6 A’s Addressed
Dye [47] Assam Province, India 
(1875–1950)
Anthroponotic VL (L. 
donovani)
Epidemic data from Rogers 
(1908) [69], McCombie 
Young (1924) [70], and Sen 
Gupta (1951) [71]
Discrete-time com-
partmental model
×
Hasibeder [48] × Canine leishmaniasis, L. 
infantum
× ODEs ×
Dye [49] Gozo island in Malta 
(June–July 1989)
Canine leishmaniasis, L. 
infantum
cross-sectional survey includ-
ing age-structured serologi-
cal data
Used results from 
ODEs in [48]
×
Dye [50] Tropical America, Mediter-
ranean, and China
Canine and human 
zoonotic VL, L. infantum
Cohort study of dogs 
(Unpublished data, Quinell 
RJ, Courtenay O, and Dye C) 
and estimates from [49]
ODEs ×
Stauch [51] India, Nepal, Bangladesh 
(2006–2008)
Anthroponotic VL - L. 
donovani
KalaNet project 
(ClinicalTrials,gov 
NCT00318721)
ODEs ×
Stauch [52] Bihar, India (1980–1997) anthroponotic VL Treatment failure rate of anti-
monial treatment obtained 
from review of clinical trials 
[72]
ODEs ×
Stauch [53] India, Nepal, Bangladesh 
(2006–2008)
Anthroponotic VL KalaNet project ODEs ×
Mubayi [3] Bihar, India (2003–2005) Anthroponotic VL Monthly incidence from 21 
districts
Staged-progression 
model
×
ELmojtaba [54–56] Sudan Zoonotic VL Parameter estimates from 
literature
ODE ×
Sevá [57] Brazil (approx. 1990s and 
2000s)
Canine and human 
zoonotic VL, L. infantum
Parameters taken from pub-
lished studies, oral commu-
nication, or assumed
ODEs ×
Aparicio [58] United States TB U.S. and Massachusetts 
Census data and Parameter 
estimates from literature
ODEs and an age-
structured PDE 
model
Atmosphere
Lipsitch [59] TB Stochastic-determin-
istic hybrid model
Adherence
Mason [61] United States (approx. 
1995–2004)
Type II diabetes Electronic Medical Records, 
Administrative medical and 
pharmacy claims data, and 
Healthcare Effectiveness 
Data
Discounted Markov 
Decision Process
Adherence
Hallet [62] Zimbabwe (1980s–2000s) HIV HIV prevalence and sexual 
behaviour surveillance data
ODEs and a Bayesian 
Melding framework
Awareness
Mushayabasa [63] × Hepatitis C Epidemiological data from 
literature
ODEs Awareness
Fenichel [64] Economic behavioral 
model/SIR
Awareness
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initiation and drug-adherence in diabetes patients and the 
role these two factors play in determining a patients’ quality-
adjusted life years (QALYs). Consistent with observations of 
adherence behavior in diabetes patients, the model assumed 
that a patient’s health status does not influence future 
adherence. This assumption may be relevant for some VL-
endemic regions where non-adherence is a consequence 
of insufficient inculcation of the risks associated with 
improper treatment, or a result of the cost of treatment. The 
model also assumed, consistent with clinical practice, that if 
a patient or the patient’s physician had not already decided 
to begin treatment, treatment would be immediately initi-
ated following a non-fatal complication. The reward func-
tion, dependent on adherence, included several important 
factors, including QALY, the cost of treatment and hospital-
ization, and disutility resulting from treatment side effects. 
The authors also developed a cost function, with the goal of 
optimizing treatment initiation, in the presence of different 
degrees of non-adherence, and compared the optimal tim-
ing for ‘uncertain adherence’ and ‘predictable adherers’. The 
authors quantified the benefit of treatment relative to the 
cost through a reward function rt(l,m), where l denoted the 
patient’s health status, and m equaled zero or one, depend-
ing on whether the patient was on treatment or not.
for t = 1, . . . ,T − 1, l ∈ L,m ∈ M, where
describes the reward for 1 quality-adjusted life. The decre-
ment factors dS , dCHD, and dST denote the decrease in qual-
ity of life from a stroke (S), a coronary heart disease (CHD) 
event, or statins initiation (SI), respectively. The costs 
CO,CST ,CS and CCHD, and CFS and CFCHD represent the 
cost of other health care for diabetes patients, cost of sta-
tin treatment, cost of initial hospitalization for stroke and 
CHD events, and cost of follow-up treatment for stroke and 
CHD events, respectively. This diabetes model suggested 
that initiation of treatment should be delayed in individu-
als predicted to have poor future adherence. Furthermore, 
the model predicted that over time, only 25% of patients will 
remain adherers for greater than 80% of the days during the 
study.
Modeling awareness
The effect of change in disease dynamics due to behav-
ioral change and educational awareness have been mod-
eled using ordinary differential equations-based models 
in several studies. Hallett et  al. analyzed the effect of 
behavior change on the course of an HIV epidemic [62]. 
rt(l,m) = R(l,m)− C
0
t − (CF
S(l)+ CFCHD(l))
−mCST (A)− (CS(l)+ CCHD(l)),
R(l,m) = R0(d
S(l))(dCHD(l))(mdST (A)),
l ∈ L, m ∈M
In their dynamic model, the behavior is incorporated 
by considering parameters such as mean rate of part-
ner change and condom use in casual relationship as a 
step-function depending on time at which the change in 
behavior occurred and time it takes to reach a new value. 
In Mushayabasa et  al., an ordinary differential equation 
model was used to quantify the role of an educational 
campaign in controlling Hepatitis C among women in 
prison [63]. Here, the effect of this campaign is reflected 
as an efficacy factor in conjunction to the parameters 
which represent the sharing of contaminated needles or 
syringes among the susceptible and exposed classes.
Ideas for VL modeling should also draw from modeling 
techniques used in economics in the context of social 
sciences to effectively optimize the cost and strategy in 
a resource-limited region. Fenichel et  al. used an eco-
nomic behavioral model in conjunction with the classical 
Susceptible-Infected-Recovered (SIR) model that explic-
itly models adaptive contact behavior [64]. The authors 
construct a utility function, an index which describes 
an individual’s well-being. The framework assumes that 
individuals make choices that maximize their utility. 
These decisions then impact disease risk, creating a feed-
back loop between disease risk and decisions made based 
on perceived disease risk. The authors demonstrate that 
fitting the classical SIR model to data generated by their 
new framework results in erroneous estimates of epide-
miological parameters, because of its inability to jointly 
estimate behavioral and biological parameters. See Per-
rings et al. for a thorough review on the growing topic of 
economic epidemiology [65].
Bridging the gap
The results of models addressing adherence to treat-
ment, adaptive human behavior, and resource constraints 
emphasize the need to bridge the gap between socio-
economic factors and existing mathematical modeling 
frameworks. Models of other vector borne diseases have 
captured some of the critical factors for visceral leish-
maniasis (“Models of infectious diseases incorporating 
socio-economic risk actors” section). However, there is 
need for a more comprehensive set of frameworks that 
can incorporate local VL risk factors at multiple scales 
in the same dynamical model. The 6 A’s should be sys-
tematically incorporated into VL model frameworks to 
assess the sensitivity of VL dynamics to these six socio-
economic factors. A schematic diagram depicting one 
such inter-dependent modeling framework is given in 
Fig. 3. Failing to address factors that result in significant 
changes in disease dynamics may result in models that 
do not effectively inform public health policy. Likewise, 
models that do not acknowledge resource constraints 
may lead to infeasible control policies.
Page 11 of 14DebRoy et al. Emerg Themes Epidemiol  (2017) 14:10 
Discussion
NTDs, including VL, continue to spread in almost 
every continent on the planet, particularly in the poor-
est regions of modern human civilization [66, 67]. The 
campaign to eliminate VL from the Indian sub-continent, 
endorsed by the WHO, were set twice in the past (2010 
and 2015) but target goals were not met [10]. The rea-
sons for the ongoing spread and failure to control VL are 
thought to be mainly contributed by underreporting of 
cases [3], poor infrastructure, lack of awareness, poverty 
and inadequate control measures. In this review we have 
presented some of the less highlighted, but nonetheless 
critical factors/mechanisms, which are key in one of the 
worst VL affected impoverished regions, especially in 
the Indian state of Bihar. These factors may also play an 
important role in the transmission of other NTDs [3].
Mathematical models have been used to understand 
transmission dynamics of other tropical infections and 
strategize control measures under relevant constraints 
with varied success. Moreover, recent development of 
effective modeling techniques for infectious diseases, 
new sophisticated parameterizations methods [68] and 
useful validation tools have provided significant assis-
tance to decision makers. However, modeling based 
study for evaluating temporal policies for NTDs are 
either limited or use risk factors that are known for 
well studied diseases. We suggest novel critical risk 
factors needed for effectively studying long term poli-
cies for NTDs and requires a rethinking of the man-
ner in which address regional issues. There is a need 
for more modeling-based studies for NTDs, including 
for VL, that comprehensively address the six risk fac-
tors identified in this manuscript: Atmosphere, Access, 
Availability, Awareness, Adherence, and Accedence. 
Models that incorporate diverse local conditions as 
shown in Fig. 3 will allow formulation of effective pub-
lic health strategies which will alleviate the burden 
of VL in under-developed regions like Bihar  with it’s 
resource constraints. Thus, we propose mathematical 
modeling as an efficient and cost-effective tool to devise 
Fig. 3 Caricature of critical categories of modeling frameworks for studying dynamics of vector-borne diseases (green rhombus), types of data 
needed in such frameworks (orange oval) and their potential links (red arrow). SV and IV represent densities of susceptible and infectious vectors. SH
, AH, IH and RH are human epidemiological stages representing susceptible, asymptomatic, infectious, and recovered stages. 1st and 2nd line are for 
types of treatments whereas DAT and rk39 are for diagnostic methods. Light green box represents the output from respective modeling frameworks. 
These frameworks are mere examples in each categories and hence, each one of them can incorporate more details depending on the goals
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meaningful control measures that will make the next 
WHO leishmaniasis elimination goal successful. Mod-
eling studies are heavily dependent on the availability 
of region-specific surveillance, entomological and eco-
logical data, and maintenance of a such database is also 
important for these regions where large scale integrated 
control programs are being introduced to achieve 
elimination.
In light of the major financial constraints in the affected 
regions, a hybrid dynamic optimization model (an exam-
ple framework is shown in Fig.  3) will be necessary to 
explicitly calculate monetary (cost of interventions) and 
non-monetary (mortality and morbidity) factors related 
to VL. The building of such a model will require detailed 
quantification of every aspect of life in the regions, 
including non-tangible issues discussed here. Moreover, 
the execution of this model will require extensive sets of 
data on these varied aspects, which is challenging consid-
ering the current dearth of data. This will elucidate our 
understanding of the magnitude of this problem and esti-
mate the relative importance of different socio-economic 
factors; thus, accurately predicting disease dynamics and 
informing effective public health policies.
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